IP Library Assignment 036585/0956
Patent Assignment
Reel/Frame 036585/0956

Assignment of Assignor's Interest

Recorded: 2015-09-10 Pages: 26
Assignor
BRISTOL-MYERS SQUIBB COMPANY
Executed: 2015-07-01
Assignee
R-PHARM US OPERATING LLC
100 OVERLOOK CENTER, 2ND FLOOR, PRINCETON, NEW JERSEY, 08540
Covered Properties (57)
Epothilone Derivatives
Patent: 6,605,599 →
Application: 09/084,542 →
Process for the Preparation of Ring-Opened Epothilone Intermediates Which Are Useful for the Preparation of Epothilone Analogs
Patent: 6,365,749 →
Application: 09/170,582 →
Process for the preparation of epothilone analogs
Application: 09/528,526 →
Process for the Preparation of Epothilone Analogs
Patent: 6,518,421 →
Application: 09/775,361 →
Polymorphs of an Epothilone Analog
Patent: 6,689,802 →
Application: 09/925,112 →
Publication: US 2002/0188014
Process for the preparation of epothilone analogs
Application: 09/946,721 →
Publication: US 2003/0004338
Parenteral Formulation for Epothilone Analogs
Patent: 7,022,330 →
Application: 10/051,727 →
Publication: US 2002/0143038
Methods of Administering Epothilone Analogs for the Treatment of Cancer
Patent: 6,670,384 →
Application: 10/055,653 →
Publication: US 2002/0169190
Pharmaceutical Compositions, Dosage Forms and Methods for Oral Administration of Epothilones
Patent: 6,576,651 →
Application: 10/057,390 →
Publication: US 2002/0177615
Treatment of Refractory Tumors Using Epothilone Derivatives
Patent: 6,686,380 →
Application: 10/072,123 →
Publication: US 2002/0165258
Combination of Epothilone Analogs and Chemotherapeutic Agents for the Treatment of Proliferative Diseases
Patent: 7,312,237 →
Application: 10/091,061 →
Publication: US 2003/0073677
Epothilone Derivatives
Patent: 7,125,899 →
Application: 10/405,886 →
Publication: US 2003/0220295
Methods for the Preparation, Isolation and Purification of Epothilone B, and X-Ray Crystal Structures of Epothilone B
Patent: 7,172,884 →
Application: 10/668,032 →
Publication: US 2004/0132146
Polymorphs of an Epothilone Analog
Patent: 6,982,276 →
Application: 10/773,819 →
Publication: US 2004/0157897
Methods for the Preparation, Isolation and Purification of Epothilone B, and X-Ray Crystal Structures of Epothilone B
Patent: 7,241,899 →
Application: 10/805,724 →
Publication: US 2006/0135474
Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
Patent: 8,569,347 →
Application: 10/850,072 →
Publication: US 2004/0214871
Process and formulation containing epothilones and analogs thereof
Application: 10/979,958 →
Publication: US 2005/0171167
Combination of epothilone analogs and chemotherapeutic agents for the treatment of prolferative diseases
Application: 11/009,579 →
Publication: US 2005/0159461
Process for the Preparation of Epothilone Analogs
Patent: 39,356 →
Application: 11/056,606 →
Polymorphs of an Epothilone Analog
Patent: 39,251 →
Application: 11/076,589 →
Pharmaceutical Compositions, Dosage Forms and Methods for Oral Administration of Epothilones
Patent: 40,387 →
Application: 11/149,501 →
Parenteral formulation for epothilone analogs
Application: 11/226,017 →
Publication: US 2006/0013836
Polymorphs of an Epothilone Analog
Patent: 7,153,879 →
Application: 11/271,456 →
Publication: US 2006/0063815
Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
Application: 11/289,102 →
Publication: US 2006/0121511
Treatment of Refractory Tumors Using Epothilone Derivatives
Patent: 41,393 →
Application: 11/346,579 →
Epothilone Derivatives
Patent: 7,241,755 →
Application: 11/512,623 →
Publication: US 2006/0287371
Methods for the Preparation, Isolation and Purification of Epothilone B, and X-Ray Crystal Structures of Epothilone B
Patent: 7,767,432 →
Application: 11/669,268 →
Publication: US 2007/0122891
Epothilone Derivatives
Patent: 8,536,327 →
Application: 11/763,636 →
Publication: US 2007/0255055
Methods for Determining Sensitivity to Microtubule-Stabilizing Agents Comprising Ixabepilone by Measuring the Level of Estrogen Receptor 1
Patent: 7,932,031 →
Application: 11/906,248 →
Publication: US 2008/0318228
Parenteral Formulation for Epothilone Analogs
Patent: 8,632,788 →
Application: 12/264,375 →
Publication: US 2009/0069393
Methods for the Preparation, Isolation and Purification of Epothilone B, and X-Ray Crystal Structures of Epothilone B
Patent: 42,191 →
Application: 12/462,816 →
Combination of Epothilone Analogs and Chemotherapeutic Agents for the Treatment of Proliferative Diseases
Patent: 8,598,215 →
Application: 12/508,100 →
Publication: US 2010/0015149
Methods for the Preparation, Isolation and Purification of Epothilone B, and X-Ray Crystal Structures of Epothilone B
Application: 12/537,287 →
Epothilone Derivatives
Patent: 41,911 →
Application: 12/539,492 →
Epothilone Derivatives
Patent: 41,895 →
Application: 12/539,496 →
Epothilone Derivatives
Patent: 41,893 →
Application: 12/539,498 →
Process and Formulation Containing Epothilones and Analogs Thereof
Patent: 8,871,227 →
Application: 12/557,822 →
Publication: US 2010/0016385
Epothilone Derivatives
Patent: 43,003 →
Application: 12/882,769 →
Combination of Epothilone Analogs and Chemotherapeutic Agents for the Treatment of Proliferative Diseases
Application: 12/906,511 →
Publication: US 2011/0033457
Epothilone Derivatives
Patent: 8,921,542 →
Application: 13/966,613 →
Publication: US 2013/0331564
Parenteral Formulation for Epothilone Analogs
Application: 14/134,172 →
Publication: US 2014/0107169
Epothilone Derivatives
Application: 14/553,081 →
Publication: US 2015/0080440
Parenteral Formulation for Epothilone Analogs
Application: 14/686,005 →
Publication: US 2015/0218179
Epothilone Derivatives
Application: 60/051,951 →
Epoithilone Derivatives
Application: 60/067,524 →
Process for the Preparation of Ring-Opened Epothilone Intermediates Which Are Useful for the Preparation of Epothilone Analogs
Application: 60/067,550 →
Polymorphs of an epothilone analog
Application: 60/225,590 →
Parenteral formulation for epothilone analogs
Application: 60/264,228 →
Treatment of refractory tumors using epothilone derivatives
Application: 60/269,836 →
Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
Application: 60/275,801 →
Methods of Administering Epothilone Analogs for the Treatment of Cancer
Application: 60/290,008 →
Pharmaceutical compositions, dosage forms and methods for oral administration of epothilones
Application: 60/290,019 →
Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
Application: 60/316,395 →
Methods for the preparation, isolation and purification of epothilone B, and x-ray crystal structures of epothilone B
Application: 60/412,994 →
Process and formulation containing epothilones and analogs thereof
Application: 60/517,020 →
Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
Application: 60/631,993 →
Methods of Administering Epothilone Analogs for the Treatment of Cancer
Application: 90/007,605 →
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 4, 2004
From: BENIGNI, DANIEL; STANKAVAGE, ROBERT; CHIANG, SHU-JEN; HOU, HSING
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 014306/0981 →
Assignment of Assignor's Interest Apr 16, 2004
From: GOUGOUTAS, JACK Z.; DIMARCO, JOHN
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 014525/0426 →
Assignment of Assignor's Interest Apr 15, 2005
From: HABY, THOMAS A.; GOGATE, UDAY S.; NARINGREKAR, VIJAY H.
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 016078/0984 →
Assignment of Assignor's Interest May 8, 2007
From: FAVREAU, DENIS
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 019260/0010 →
Assignment of Assignor's Interest Jul 26, 2007
From: BORZILLERI, ROBERT M.; KIM, SOONG-HOON
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 019605/0686 →
Assignment of Assignor's Interest Feb 14, 2012
From: GERTH, KLAUS; HOEFLE, GERHARD; STEINMETZ, HEINRICH
To: HELMHOLTZ-ZENTRUM FUER INFEKTIONSFORSCHUNG GMBH
Reel/Frame 027700/0036 →
Assignment of Assignor's Interest Feb 14, 2012
From: HOEFLE, GERHARD; SASSE, FLORENZ
To: HELMHOLTZ-ZENTRUM FUER INFEKTIONSFORSCHUNG GMBH
Reel/Frame 027700/0283 →